Coherus BioSciences, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
0.8386
-0.0124 (-1.46%)
At close: Mar 28, 2025, 4:00 PM
0.8451
+0.0065 (0.78%)
After-hours: Mar 28, 2025, 7:59 PM EDT
Coherus BioSciences Employees
Coherus BioSciences had 228 employees as of December 31, 2024. The number of employees decreased by 78 or -25.49% compared to the previous year.
Employees
228
Change (1Y)
-78
Growth (1Y)
-25.49%
Revenue / Employee
$1,170,877
Profits / Employee
$125,031
Market Cap
97.19M
Employees Chart
CHRS News
- 3 days ago - Coherus to Present Data from a Phase 1 Dose Expansion Study of CHS-114, a Cytolytic Antibody Targeting Chemokine Receptor 8 (CCR8), at the 2025 American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire
- 18 days ago - Coherus BioSciences, Inc. (CHRS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 18 days ago - Coherus BioSciences Reports Fourth Quarter, Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 25 days ago - Coherus to Report Fourth Quarter and Full Year 2024 Financial Results on March 10, 2025 - GlobeNewsWire
- 4 weeks ago - Coherus Management to Participate at the 45th Annual TD Cowen Health Care Conference - GlobeNewsWire
- 3 months ago - Coherus to Present Final Phase 2 Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025 - GlobeNewsWire
- 3 months ago - Coherus BioSciences: Shedding Pegfilgrastim To Fuel Ongoing Development - Seeking Alpha
- 4 months ago - Why Is Coherus BioSciences Stock Trading Higher On Tuesday? - Benzinga